Flagship Ventures Fund V General Partner LLC - 10%+ Owner at Sigilon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
SGTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Flagship Ventures Fund V General Partner LLC since 7/7/2023

Holdings reported by Flagship Ventures Fund V General Partner LLC for Sigilon Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 0 $14.92 Aug 11, 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Common Stock 0 $14.92 Aug 11, 2023 By Flagship Ventures Fund V, L.P.

Transactions reported by Flagship Ventures Fund V General Partner LLC for Sigilon Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership